Halozyme Therapeutics, Inc. (HALO): R&D Expense
$81.49M
Year ended 2025-12-31
$102.37M
Trailing 12 months to 2026-06-30
+7.0%
3-year compound annual growth
+18.9%
5-year compound annual growth
-1.3%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $81.49M | +3.1% | 2026-02-17, From 2025-01-01 |
| 2024-12-31 | $79.05M | +3.5% | 2026-02-17, From 2024-01-01 |
| 2023-12-31 | $76.36M | +14.6% | 2026-02-17, From 2023-01-01 |
| 2022-12-31 | $66.61M | +86.7% | 2025-02-18, From 2022-01-01 |
| 2021-12-31 | $35.67M | +4.2% | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | $34.24M | -75.7% | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | $140.80M | -6.3% | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | $150.25M | -0.3% | 2021-02-23, From 2018-01-01 |
| 2017-12-31 | $150.64M | -0.1% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $150.84M | +61.8% | 2019-02-21, From 2016-01-01 |
| 2015-12-31 | $93.24M | +17.0% | 2018-02-20, From 2015-01-01 |
| 2014-12-31 | $79.70M | -17.5% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $96.64M | +38.0% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $70.04M | +21.7% | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | $57.56M | +11.2% | 2014-02-28, From 2011-01-01 |
| 2010-12-31 | $51.77M | -8.6% | 2013-03-01, From 2010-01-01 |
| 2009-12-31 | $56.61M | n/a | 2012-03-12, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Halozyme Therapeutics, Inc. (HALO) | 2025-12-31 | $81.49M | +3.1% |
| Bio-Techne Corp (TECH) | 2026-06-30 | $94.77M | -4.8% |
| Novavax Inc (NVAX) | 2025-12-31 | $342.32M | -12.5% |
| Moderna, Inc. (MRNA) | 2025-12-31 | $3.13B | -31.1% |
| Qiagen N.V. (QGEN) | 2025-12-31 | $187.52M | -3.1% |
| BioCryst Pharmaceuticals Inc (BCRX) | 2025-12-31 | $166.13M | -4.9% |
| Exelixis, Inc. (EXEL) | 2026-01-02 | $825.00M | -9.4% |
| Repligen Corp (RGEN) | 2025-12-31 | $54.18M | +25.4% |
| Neurocrine Biosciences Inc (NBIX) | 2025-12-31 | $1.02B | +38.9% |
Compare HALO, TECH, NVAX, MRNA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗